Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes

Cell Signal. 2017 Jun:34:23-37. doi: 10.1016/j.cellsig.2017.02.019. Epub 2017 Feb 22.

Abstract

Proliferating cells depend on glycolysis mainly to supply precursors for macromolecular synthesis. Fructose 2,6-bisphosphate (Fru-2,6-P2) is the most potent positive allosteric effector of 6-phosphofructo-1-kinase (PFK-1), and hence of glycolysis. Mitogen stimulation of rat thymocytes with concanavalin A (ConA) led to time-dependent increases in lactate accumulation (6-fold), Fru-2,6-P2 content (4-fold), 6-phosphofructo-2-kinase (PFK-2)/fructose-2,6-bisphosphatase isoenzyme 3 and 4 (PFKFB3 and PFKFB4) protein levels (~2-fold and ~15-fold, respectively) and rates of cell proliferation (~40-fold) and protein synthesis (10-fold) after 68h of incubation compared with resting cells. After 54h of ConA stimulation, PFKFB3 mRNA levels were 45-fold higher than those of PFKFB4 mRNA. Although PFKFB3 could be phosphorylated at Ser461 by protein kinase B (PKB) in vitro leading to PFK-2 activation, PFKFB3 Ser461 phosphorylation was barely detectable in resting cells and only increased slightly in ConA-stimulated cells. On the other hand, PFKFB3 and PFKFB4 mRNA levels were decreased (90% and 70%, respectively) by exposure of ConA-stimulated cells to low doses of PKB inhibitor (MK-2206), suggesting control of expression of the two PFKFB isoenzymes by PKB. Incubation of thymocytes with ConA resulted in increased expression and phosphorylation of the translation factors eukaryotic initiation factor-4E-binding protein-1 (4E-BP1) and ribosomal protein S6 (rpS6). Treatment of ConA-stimulated thymocytes with PFK-2 inhibitor (3PO) or MK-2206 led to significant decreases in Fru-2,6-P2 content, medium lactate accumulation and rates of cell proliferation and protein synthesis. These data were confirmed by using siRNA knockdown of PFKFB3, PFKFB4 and PKB α/β in the more easily transfectable Jurkat E6-1 cell line. The findings suggest that increased PFKFB3 and PFKFB4 expression, but not increased PFKFB3 Ser461 phosphorylation, plays a role in increasing glycolysis in mitogen-stimulated thymocytes and implicate PKB in the upregulation of PFKFB3 and PFKFB4. The results also support a role for Fru-2,6-P2 in coupling glycolysis to cell proliferation and protein synthesis in this model.

Keywords: Fru-2,6-P(2); Glycolysis; PFKFB isoenzymes; PKB; Proliferation; Protein synthesis.

MeSH terms

  • Animals
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Concanavalin A / pharmacology
  • Female
  • Gene Expression / drug effects
  • Glycolysis / drug effects
  • Heterocyclic Compounds, 3-Ring / pharmacology
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Jurkat Cells
  • Phosphofructokinase-2 / antagonists & inhibitors
  • Phosphofructokinase-2 / genetics
  • Phosphofructokinase-2 / metabolism*
  • Phosphoproteins / genetics
  • Phosphoproteins / metabolism
  • Phosphorylation / drug effects
  • Protein Biosynthesis / drug effects
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Rats
  • Rats, Wistar
  • Ribosomal Protein S6 / metabolism
  • Thymocytes / cytology
  • Thymocytes / drug effects
  • Thymocytes / metabolism

Substances

  • Carrier Proteins
  • Eif4ebp1 protein, rat
  • Heterocyclic Compounds, 3-Ring
  • Intracellular Signaling Peptides and Proteins
  • MK 2206
  • Pfkfb4 protein, rat
  • Phosphoproteins
  • Ribosomal Protein S6
  • Concanavalin A
  • Pfkfb3 protein, rat
  • Phosphofructokinase-2
  • Proto-Oncogene Proteins c-akt